list glp 1 receptor agonist of approved and pending GLP-1 medications Classification of currently available glucagon-like
Description
On average, GLP-1 use leads to a modest amount of weight loss, averaging between 5-10% of body weight, while some users may not experience any weight changes
P.VelazquezE
Researchers discovered new treatment options through their discovery that GLP-1 receptor agonists used for diabetes treatment can be repurposed for new medical applications
While the study was small, it provided crucial early evidence that the approach merits further investigation
Summary: key takeaways GLP-1 receptor agonists are strongly associated with impaired gastric emptying
doi: 10.1111/dom.12539
